AKT1 and cancer: The PIK3/AKT/MTOR (phosphatidylinositol-4,5-bisphosphate 3-kinase/AKT serine-threonine kinase/mechanistic target of rapamycin kinase) is one of the most activated cell signaling routes in cancer [67].